MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202547087956 A) filed by Chugai Seiyaku Kabushiki Kaisha, Tokyo, on Sept. 16, for 'nitrogen-containing heterocyclic compound having myt1 inhibitory activity.'
Inventor(s) include Aoki Toshihiro; Chiba Takashi; Kochi Masami; Tomizawa Masaki; Murata Yoshihisa; and Suyama Eigo.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "To provide a new compound having inhibitory activity on MYT1, a salt thereof, or a solvate of the compound or salt. Provided is a compound represented by the formula, a salt thereof, or a solvate of the compound or the salt [in the formula, R4 is selected from the group consisting of optionally substituted C6 to C10 aryls (R4A), optionally substituted four- to ten-membered heterocyclyls, and optionally substituted five- to ten-membered heteroaryls (R4HA); R5 and R6, together with the atoms bonded thereto, form an optionally substituted ring D; ring D is selected from the group consisting of three- to ten-membered monocyclic alicyclic rings, a benzene ring, three- to twelve-membered monocyclic heterocycles, and five- to six-membered monocyclic aromatic heterocycles (DHA); and any two adjacent substituents on ring D, together with atoms bonded thereto, may form an optionally substituted ring E."
The patent application was internationally filed on Feb. 27, 2024, under International application No.PCT/JP2024/007072.
Disclaimer: Curated by HT Syndication.
